Pharmaceutical

SciRhom secures $70m for autoimmune diseases treatments

SciRhom has secured €63m ($70m) in a Series A funding round to develop iRhom2-targeting therapeutics for autoimmune diseases.

Jul 10, 2024 - 04:00
SciRhom secures $70m for autoimmune diseases treatments
SciRhom has secured €63m ($70m) in a Series A funding round to develop iRhom2-targeting therapeutics for autoimmune diseases.
Read the original article

Tags:

Previous Article

Roche relaunches refillable wet AMD implant two years after recall

Next Article

Taiho exercises option for Arcus Biosciences’ quemliclustat in Asia

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

CMN-005 by CoImmune for B-Cell Non-Hodgkin Lymphoma: Li...

Sep 10, 2024

OCT-461201 by Oxford Cannabinoid Technologies for Visce...

Jun 18, 2024

Opinion: The end of affirmative action means it’s time to revise pre-med requirements

Opinion: The end of affirmative action means it’s time ...

Nov 11, 2023